ClinicalTrials.Veeva

Menu

Trocar-site Infiltration Versus TAP-block

T

Tunis University

Status

Unknown

Conditions

Laparoscopic Cholecystectomy

Treatments

Procedure: TAP block placebo
Procedure: Trocar site infiltration placebo
Procedure: Trocar-site infiltration
Procedure: TAP block

Study type

Interventional

Funder types

Other

Identifiers

NCT05094193
HTHEC-2021-29

Details and patient eligibility

About

For symptomatic gall bladder disorders (cholelithiasis and cholecystitis), laparoscopic cholecystectomy (LC) has been considered as the gold standard treatment. However, these minimally invasive technique is associated with acute moderate pain during the 24 hours postoperative, which is routinely managed using opioids. The transversus abdominis plane (TAP) block has been used as part of a multimodal analgesia strategy. Besides, Wang et al found that TAP block is more effective than a conventional pain control, but not significatively different from another local incisional pain control that is port site infiltration.So, the aim of this study, is to compare the analgesic efficacy and safety of trocar-site infiltration with ropivacaine with ultrasound-guided TAP block following laparoscopic cholecystectomy when used as part of multimodal analgesia.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • BMI < 30 kg/m2
  • Scheduled for laparoscopic cholecystectomy
  • ASA grade I, II and III

Exclusion criteria

  • Bile duct exploration, insertion of a T-drain or patients with acute cholecystitis
  • Conversion to open cholecystectomy or if the surgery exceeded 200 minutes
  • Severe systemic disease
  • Patients on analgesics for any reason
  • History of allergy to local anesthetics
  • An ongoing pregnancy
  • Patient refusal

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

Triple Blind

100 participants in 2 patient groups

Trocar-site infiltration
Experimental group
Description:
Trocar-site infiltration with 20 mL of ropivacaine 0.375% (6 mL in 10 mm trocar site and 4 mL in 5 mm trocar site) associated with bilateral TAP block with 20 mL of normal saline in each side
Treatment:
Procedure: TAP block placebo
Procedure: Trocar-site infiltration
TAP block
Active Comparator group
Description:
Trocar-site infiltration with 20 mL of normal saline associated with bilateral TAP block with 20 mL of ropivacaine 0.375% in each side
Treatment:
Procedure: TAP block
Procedure: Trocar site infiltration placebo

Trial contacts and locations

1

Loading...

Central trial contact

DAGHMOURI Mohamed Aziz, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems